• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降低阿片类药物所致耐受性和痛觉过敏发生率的药理学原理:综述

A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A Review.

作者信息

Varrassi Giustino, Fusco Mariella, Skaper Stephen D, Battelli Daniele, Zis Panagiotis, Coaccioli Stefano, Pace Maria Caterina, Paladini Antonella

机构信息

Department of Anesthesia and Pain Medicine, University of L'Aquila, L'Aquila, Italy.

Center for Medical Documentation and Information, Epitech, Padua, Italy.

出版信息

Pain Ther. 2018 Jun;7(1):59-75. doi: 10.1007/s40122-018-0094-9. Epub 2018 Mar 28.

DOI:10.1007/s40122-018-0094-9
PMID:29594972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5993687/
Abstract

Chronic pain is an important health and social problem. Misuse and abuse of opioids in chronic non-cancer pain management seem to be a huge problem, in some countries. This could probably affect the normal use of such analgesics in patients in need of them. Basic and clinical researches should find the solution to mitigate the potential damage. Dysregulation of mast cell and microglia activation plays an important role in the pathogenesis and management of chronic pain. Persistent mast cell activation sensitizes nociceptors and initiates central nervous system inflammatory processes, involving microglial cell activation and sensitization of spinal somatosensory neurons. Exposure of mast cells and microglia to opioids is well known to provoke activation of these non-neuronal immune cell populations, thereby contributing to an exacerbation of pro-inflammatory and pro-nociceptive processes and promoting, over the long-term, opioid-induced hyperalgesia and tolerance. This review is intended to provide the reader with an overview of the role for these non-neuronal cells in opioid-induced chronic pain and tolerance as a consequence of prolonged exposure to these drugs. In addition, we will examine a potential strategy with the aim to modulate opioid-induced over-activation of glia and mast cells, based on endogenous defense mechanisms and fatty acid amide signaling molecules.

摘要

慢性疼痛是一个重要的健康和社会问题。在一些国家,慢性非癌性疼痛管理中阿片类药物的误用和滥用似乎是一个巨大的问题。这可能会影响到有需要的患者对这类镇痛药的正常使用。基础研究和临床研究应找到减轻潜在损害的解决办法。肥大细胞和小胶质细胞激活失调在慢性疼痛的发病机制和管理中起着重要作用。持续的肥大细胞激活会使伤害感受器敏感化,并启动中枢神经系统炎症过程,包括小胶质细胞激活和脊髓体感神经元敏感化。众所周知,肥大细胞和小胶质细胞暴露于阿片类药物会引发这些非神经元免疫细胞群体的激活,从而导致促炎和促痛觉过程加剧,并长期促进阿片类药物诱导的痛觉过敏和耐受性。本综述旨在为读者概述这些非神经元细胞在长期接触这些药物导致的阿片类药物诱导的慢性疼痛和耐受性中的作用。此外,我们将基于内源性防御机制和脂肪酸酰胺信号分子,研究一种潜在策略,旨在调节阿片类药物诱导的胶质细胞和肥大细胞过度激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948f/5993687/66997d531d42/40122_2018_94_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948f/5993687/890712329f53/40122_2018_94_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948f/5993687/66997d531d42/40122_2018_94_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948f/5993687/890712329f53/40122_2018_94_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/948f/5993687/66997d531d42/40122_2018_94_Fig2_HTML.jpg

相似文献

1
A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A Review.降低阿片类药物所致耐受性和痛觉过敏发生率的药理学原理:综述
Pain Ther. 2018 Jun;7(1):59-75. doi: 10.1007/s40122-018-0094-9. Epub 2018 Mar 28.
2
Differential Spinal and Supraspinal Activation of Glia in a Rat Model of Morphine Tolerance.吗啡耐受大鼠模型中胶质细胞的脊髓和脊髓上差异激活。
Neuroscience. 2018 Apr 1;375:10-24. doi: 10.1016/j.neuroscience.2018.01.048. Epub 2018 Feb 6.
3
Opioid tolerance and opioid-induced hyperalgesia: Is TrkB modulation a potential pharmacological solution?阿片类药物耐受和阿片类药物诱导的痛觉过敏:TrkB 调节是否是一种潜在的药理学解决方案?
Neuropharmacology. 2022 Dec 1;220:109260. doi: 10.1016/j.neuropharm.2022.109260. Epub 2022 Sep 19.
4
Glial Modulation in Pain States: Translation into Humans疼痛状态下的胶质细胞调节:向人体转化
5
Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility.Toll 样受体 4(TLR4)/阿片受体通路串扰及其对阿片类药物镇痛、免疫功能和胃肠道动力的影响。
Front Immunol. 2020 Jul 8;11:1455. doi: 10.3389/fimmu.2020.01455. eCollection 2020.
6
Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure.长期吗啡暴露导致伤害感受增强的潜在机制。
Biopolymers. 2005;80(2-3):319-24. doi: 10.1002/bip.20254.
7
Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and mu opioid receptor protein expression while enhancing perivascular microglial ED2.抑制小胶质细胞 P2X4 受体可减轻吗啡耐受,降低 Iba1、GFAP 和 μ 阿片受体蛋白表达,同时增强血管周围小胶质细胞 ED2。
Pain. 2010 Sep;150(3):401-413. doi: 10.1016/j.pain.2010.02.042. Epub 2010 Jun 22.
8
Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.伤害感受器而非小胶质细胞中μ阿片受体信号的丧失可消除吗啡耐受性,且不影响镇痛效果。
Nat Med. 2017 Feb;23(2):164-173. doi: 10.1038/nm.4262. Epub 2017 Jan 16.
9
A comprehensive review of opioid-induced hyperalgesia.阿片类药物诱导痛觉过敏的综合评价。
Pain Physician. 2011 Mar-Apr;14(2):145-61.
10
The role of neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance.神经炎症在急性疼痛向慢性疼痛转变以及阿片类药物诱导的痛觉过敏和耐受性中的作用。
Front Pharmacol. 2023 Dec 15;14:1297931. doi: 10.3389/fphar.2023.1297931. eCollection 2023.

引用本文的文献

1
Sleep Quality in Chronic Pain Patients With and Without Strong Opioid Use: An Observational Study Using a Wearable Device.使用和未使用强效阿片类药物的慢性疼痛患者的睡眠质量:一项使用可穿戴设备的观察性研究。
Neuropsychopharmacol Rep. 2025 Sep;45(3):e70052. doi: 10.1002/npr2.70052.
2
Therapeutic efficacy of thiocolchicoside-nonsteroidal anti-inflammatory drug combination in pain management: A systematic review and cross-sectional real-world study.硫代秋水仙碱-非甾体抗炎药联合用药在疼痛管理中的治疗效果:一项系统评价和横断面真实世界研究
World J Orthop. 2025 Aug 18;16(8):106769. doi: 10.5312/wjo.v16.i8.106769.
3
Gut dysbiosis was inevitable, but tolerance was not: temporal responses of the murine microbiota that maintain its capacity for butyrate production correlate with sustained antinociception to chronic morphine.

本文引用的文献

1
Pain management, prescription opioid mortality, and the CDC: is the devil in the data?疼痛管理、处方阿片类药物死亡率与美国疾病控制与预防中心:问题出在数据上吗?
J Pain Res. 2017 Oct 20;10:2489-2495. doi: 10.2147/JPR.S153322. eCollection 2017.
2
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016.2016年7月至12月,涉及芬太尼、芬太尼类似物和U-47700的死亡事件 - 10个州
MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1197-1202. doi: 10.15585/mmwr.mm6643e1.
3
Depression and chronic pain in the elderly: links and management challenges.
肠道菌群失调是不可避免的,但耐受性并非如此:维持丁酸盐产生能力的小鼠微生物群的时间反应与对慢性吗啡的持续抗伤害感受相关。
Gut Microbes. 2025 Dec;17(1):2446423. doi: 10.1080/19490976.2024.2446423. Epub 2025 Jan 12.
4
A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review.棕榈酰乙醇胺(PEA)用于慢性神经性疼痛管理的数十年征程:一项全面的叙述性综述
Pain Ther. 2025 Feb;14(1):81-101. doi: 10.1007/s40122-024-00685-4. Epub 2024 Dec 4.
5
Fentanyl enhances immune cell response through TLR4/MD-2 complex.芬太尼通过Toll样受体4/髓样分化蛋白2复合物增强免疫细胞反应。
Front Pharmacol. 2024 Oct 9;15:1468644. doi: 10.3389/fphar.2024.1468644. eCollection 2024.
6
Gut dysbiosis was inevitable, but tolerance was not: temporal responses of the murine microbiota that maintain its capacity for butyrate production correlate with sustained antinociception to chronic morphine.肠道微生物群失调不可避免,但耐受性并非如此:维持其丁酸盐产生能力的小鼠微生物群的时间反应与对慢性吗啡的持续抗伤害感受相关。
bioRxiv. 2024 Nov 27:2024.04.15.589671. doi: 10.1101/2024.04.15.589671.
7
Potential Role of Oxidative Stress in the Pathophysiology of Neurodegenerative Disorders.氧化应激在神经退行性疾病发病机制中的潜在作用。
Comb Chem High Throughput Screen. 2024;27(14):2043-2061. doi: 10.2174/0113862073280680240101065732.
8
Iatrogenic Side Effects of Pain Therapies.疼痛治疗的医源性副作用
Cureus. 2023 Sep 2;15(9):e44583. doi: 10.7759/cureus.44583. eCollection 2023 Sep.
9
Plasma Brain-Derived Neurotrophic Factor and Opioid Therapy: Results of Pilot Cross-Sectional Study.血浆脑源性神经营养因子与阿片类药物治疗:初步横断面研究结果。
Clin Med Res. 2022 Dec;20(4):195-203. doi: 10.3121/cmr.2022.1731.
10
Avoid Postoperative Pain To Prevent Its Chronification: A Narrative Review.避免术后疼痛以防止其慢性化:一项叙述性综述
Cureus. 2022 Feb 15;14(2):e22243. doi: 10.7759/cureus.22243. eCollection 2022 Feb.
老年人的抑郁症与慢性疼痛:关联及管理挑战
Clin Interv Aging. 2017 Apr 21;12:709-720. doi: 10.2147/CIA.S113576. eCollection 2017.
4
Multimodal analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadol.中重度疼痛的多模式镇痛:右酮洛芬与曲马多新固定组合的作用
Curr Med Res Opin. 2017 Jun;33(6):1165-1173. doi: 10.1080/03007995.2017.1310092. Epub 2017 Apr 7.
5
Nerve growth factor: a neuroimmune crosstalk mediator for all seasons.神经生长因子:四季通用的神经免疫相互作用介质。
Immunology. 2017 May;151(1):1-15. doi: 10.1111/imm.12717. Epub 2017 Feb 21.
6
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism.前扣带回皮层中的N-棕榈酰乙醇胺通过CB1受体介导的机制间接减轻炎性疼痛行为。
Pain. 2016 Dec;157(12):2687-2696. doi: 10.1097/j.pain.0000000000000687.
7
The Opioid Epidemic in the United States.美国的阿片类药物流行问题。
Emerg Med Clin North Am. 2016 May;34(2):e1-e23. doi: 10.1016/j.emc.2015.11.002. Epub 2016 Feb 17.
8
Palmitoylethanolamide, a Special Food for Medical Purposes, in the Treatment of Chronic Pain: A Pooled Data Meta-analysis.用于医疗目的的特殊食品棕榈酰乙醇胺治疗慢性疼痛:汇总数据的荟萃分析
Pain Physician. 2016 Feb;19(2):11-24.
9
WHO analgesic ladder: a good concept gone astray.世界卫生组织镇痛阶梯:一个误入歧途的好概念。
BMJ. 2016 Jan 6;352:i20. doi: 10.1136/bmj.i20.
10
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics.疼痛与罂粟:阿片类镇痛药的利弊与危害
J Neurosci. 2015 Oct 14;35(41):13879-88. doi: 10.1523/JNEUROSCI.2711-15.2015.